American Portfolios Advisors Paratek Pharmaceuticals, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Paratek Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 16 shares of PRTK stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTK
# of Institutions
4Shares Held
1.54MCall Options Held
0Put Options Held
0About Paratek Pharmaceuticals, Inc.
- Ticker PRTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,862,500
- Description
- Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...